Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.
2.

Conantokins: peptide antagonists of NMDA receptors.

Layer RT, Wagstaff JD, White HS.

Curr Med Chem. 2004 Dec;11(23):3073-84. Review.

PMID:
15579001
3.

Antinociceptive effect of Brazilian armed spider venom toxin Tx3-3 in animal models of neuropathic pain.

Dalmolin GD, Silva CR, Rigo FK, Gomes GM, Cordeiro Mdo N, Richardson M, Silva MA, Prado MA, Gomez MV, Ferreira J.

Pain. 2011 Oct;152(10):2224-32. doi: 10.1016/j.pain.2011.04.015. Epub 2011 May 13.

PMID:
21570770
4.

N-antipyrine-3, 4-dichloromaleimide, an effective cyclic imide for the treatment of chronic pain: the role of the glutamatergic system.

Quintão NL, da Silva GF, Antonialli CS, de Campos-Buzzi F, Corrêa R, Filho VC.

Anesth Analg. 2010 Mar 1;110(3):942-50. doi: 10.1213/ANE.0b013e3181cbd7f6.

PMID:
20185671
5.

Inhibition of NMDA-induced currents by conantokin-G and conantokin-T in cultured embryonic murine hippocampal neurons.

Klein RC, Galdzicki Z, Castellino FJ.

Neuropharmacology. 1999 Dec;38(12):1819-29.

PMID:
10608277
6.

Conantokins and variants derived from cone snail venom inhibit naloxone-induced withdrawal jumping in morphine-dependent mice.

Wei J, Dong M, Xiao C, Jiang F, Castellino FJ, Prorok M, Dai Q.

Neurosci Lett. 2006 Sep 11;405(1-2):137-41. Epub 2006 Jul 20.

PMID:
16859831
7.

In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus.

White HS, McCabe RT, Armstrong H, Donevan SD, Cruz LJ, Abogadie FC, Torres J, Rivier JE, Paarmann I, Hollmann M, Olivera BM.

J Pharmacol Exp Ther. 2000 Jan;292(1):425-32.

9.

Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.

Medvedev IO, Malyshkin AA, Belozertseva IV, Sukhotina IA, Sevostianova NY, Aliev K, Zvartau EE, Parsons CG, Danysz W, Bespalov AY.

Neuropharmacology. 2004 Aug;47(2):175-83.

PMID:
15223296
10.

NR2B-selective conantokin peptide inhibitors of the NMDA receptor display enhanced antinociceptive properties compared to non-selective conantokins.

Xiao C, Huang Y, Dong M, Hu J, Hou S, Castellino FJ, Prorok M, Dai Q.

Neuropeptides. 2008 Oct-Dec;42(5-6):601-9. doi: 10.1016/j.npep.2008.09.003. Epub 2008 Nov 7.

11.
12.
13.
14.

Novel conantokins from Conus parius venom are specific antagonists of N-methyl-D-aspartate receptors.

Teichert RW, Jimenez EC, Twede V, Watkins M, Hollmann M, Bulaj G, Olivera BM.

J Biol Chem. 2007 Dec 21;282(51):36905-13. Epub 2007 Oct 25.

15.

GV196771A, an NMDA receptor/glycine site antagonist, attenuates mechanical allodynia in neuropathic rats and reduces tolerance induced by morphine in mice.

Quartaroli M, Fasdelli N, Bettelini L, Maraia G, Corsi M.

Eur J Pharmacol. 2001 Nov 2;430(2-3):219-27.

PMID:
11711034
16.

Antinociceptive effects of NMDA and non-NMDA receptor antagonists in the tail flick test in mice.

Lutfy K, Cai SX, Woodward RM, Weber E.

Pain. 1997 Mar;70(1):31-40.

PMID:
9106807
17.

Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.

Tan-No K, Esashi A, Nakagawasai O, Niijima F, Tadano T, Sakurada C, Sakurada T, Bakalkin G, Terenius L, Kisara K.

Brain Res. 2002 Oct 11;952(1):7-14.

PMID:
12363399
18.

The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs.

Barton ME, White HS, Wilcox KS.

Epilepsy Res. 2004 Mar;59(1):13-24.

PMID:
15135163
19.

Point mutations identify the glutamate binding pocket of the N-methyl-D-aspartate receptor as major site of conantokin-G inhibition.

Wittekindt B, Malany S, Schemm R, Otvos L, Maccecchini ML, Laube B, Betz H.

Neuropharmacology. 2001 Nov;41(6):753-61.

PMID:
11640930
20.

Structure-activity studies of conantokins as human N-methyl-D-aspartate receptor modulators.

Nielsen KJ, Skjaerbaek N, Dooley M, Adams DA, Mortensen M, Dodd PR, Craik DJ, Alewood PF, Lewis RJ.

J Med Chem. 1999 Feb 11;42(3):415-26.

PMID:
9986713

Supplemental Content

Support Center